Bora Pharmaceuticals Co (TPE:6472) Total Tax Payable: NT$432 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6472 Bora Pharmaceuticals Co Ltd TPE:6472
82 GF Score
Price NT$417.50
GF Value NT$735.59
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Bora Pharmaceuticals Co Total Tax Payable?

Bora Pharmaceuticals Co TPE:6472 -0.24% 82 Total Tax Payable is NT$432 Mil as of Mar. 2026. GuruFocus rates TPE:6472 with a GF Score™ of 82/100 and a GF Value™ of NT$735.59 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Bora Pharmaceuticals Co's Total Tax Payable for the quarter that ended in Mar. 2026 was NT$432 Mil.

Bora Pharmaceuticals Co's quarterly Total Tax Payable increased from Sep. 2025 (NT$231 Mil) to Dec. 2025 (NT$321 Mil) and increased from Dec. 2025 (NT$321 Mil) to Mar. 2026 (NT$432 Mil).

Bora Pharmaceuticals Co's annual Total Tax Payable declined from Dec. 2023 (NT$987 Mil) to Dec. 2024 (NT$484 Mil) and declined from Dec. 2024 (NT$484 Mil) to Dec. 2025 (NT$321 Mil).

Bora Pharmaceuticals Co Total Tax Payable Related Terms

Bora Pharmaceuticals Co Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Bora Pharmaceuticals Co's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bora Pharmaceuticals Co Total Tax Payable Chart

Bora Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.58 238.65 987.43 484.33 321.05

Bora Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 693.47 363.62 230.97 321.05 432.32
TPE:6472
82GF Score
Bora Pharmaceuticals Co Ltd TPE:6472
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bora Pharmaceuticals Co Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of NT$432 Mil mean?
Bora Pharmaceuticals Co (TPE:6472) has a Total Tax Payable of NT$432 Mil as of Mar. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Bora Pharmaceuticals Co and its competitors.
Is Bora Pharmaceuticals Co's Total Tax Payable too high?
Bora Pharmaceuticals Co's current Total Tax Payable is NT$432 Mil. Overall, Bora Pharmaceuticals Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bora Pharmaceuticals Co's Total Tax Payable compare to ZTS?
Bora Pharmaceuticals Co's Total Tax Payable of NT$432 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Bora Pharmaceuticals Co and its competitors. Bora Pharmaceuticals Co's current Total Tax Payable is NT$432 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bora Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Bora Pharmaceuticals Co (TPE:6472) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$735.59, compared to a current price of NT$417.50 — trading 43.2% below its estimated fair value. The current Total Tax Payable is NT$432 Mil. Bora Pharmaceuticals Co's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Bora Pharmaceuticals Co (TPE:6472), the current Total Tax Payable is NT$432 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bora Pharmaceuticals Co (TPE:6472) Overvalued in 2026?

Based on GuruFocus' analysis, Bora Pharmaceuticals Co stock appears to be undervalued. The current stock price of NT$417.50 is trading 43.2% below its estimated GF Value™ of NT$735.59. GuruFocus considers Bora Pharmaceuticals Co to be Significantly Undervalued.

Key valuation signals for TPE:6472:

  • Total Tax Payable: NT$432 Mil
  • GF Value™: NT$735.59 vs. price of NT$417.50 (43.2% below fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the TPE:6472 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bora Pharmaceuticals Co Business Description

Other Exchanges BORAY:USA
Address No. 2, Aly. 36, Lane 26, Ruiguang Road, 6th Floor, Neihu District, Taipei, TWN, 114
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Sales segment: sale of pharmaceuticals, generics, and healthcare products. CDMO segment: contract development and manufacturing organization of pharmaceuticals. Other segment: Others. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.
82GF Score

Get the complete analysis for TPE:6472

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$417.50
Price
NT$735.59
GF Value